These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 11360182)

  • 1. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front.
    Paweletz CP; Charboneau L; Bichsel VE; Simone NL; Chen T; Gillespie JW; Emmert-Buck MR; Roth MJ; Petricoin III EF; Liotta LA
    Oncogene; 2001 Apr; 20(16):1981-9. PubMed ID: 11360182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced redundancy in Akt and mitogen-activated protein kinase-induced survival of malignant versus normal prostate epithelial cells.
    Uzgare AR; Isaacs JT
    Cancer Res; 2004 Sep; 64(17):6190-9. PubMed ID: 15342404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer.
    Malik SN; Brattain M; Ghosh PM; Troyer DA; Prihoda T; Bedolla R; Kreisberg JI
    Clin Cancer Res; 2002 Apr; 8(4):1168-71. PubMed ID: 11948129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.
    Majumder PK; Febbo PG; Bikoff R; Berger R; Xue Q; McMahon LM; Manola J; Brugarolas J; McDonnell TJ; Golub TR; Loda M; Lane HA; Sellers WR
    Nat Med; 2004 Jun; 10(6):594-601. PubMed ID: 15156201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics.
    Dai B; Kong YY; Ye DW; Ma CG; Zhou X; Yao XD
    BJU Int; 2009 Oct; 104(7):1009-16. PubMed ID: 19389013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-level expression of fatty acid synthase in human prostate cancer tissues is linked to activation and nuclear localization of Akt/PKB.
    Van de Sande T; Roskams T; Lerut E; Joniau S; Van Poppel H; Verhoeven G; Swinnen JV
    J Pathol; 2005 Jun; 206(2):214-9. PubMed ID: 15880754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal pathway profiling of prostate cancer using reverse phase protein arrays.
    Grubb RL; Calvert VS; Wulkuhle JD; Paweletz CP; Linehan WM; Phillips JL; Chuaqui R; Valasco A; Gillespie J; Emmert-Buck M; Liotta LA; Petricoin EF
    Proteomics; 2003 Nov; 3(11):2142-6. PubMed ID: 14595813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer.
    Ropiquet F; Giri D; Kwabi-Addo B; Mansukhani A; Ittmann M
    Cancer Res; 2000 Aug; 60(15):4245-50. PubMed ID: 10945637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal prostate epithelial cells stimulate the migration of prostate cancer cells.
    Yu HM; Frank DE; Zhang J; You X; Carter WG; Knudsen BS
    Mol Carcinog; 2004 Oct; 41(2):85-97. PubMed ID: 15378647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation status of Fas-associated death domain-containing protein (FADD) is associated with prostate cancer progression.
    Shimada K; Matsuyoshi S; Nakamura M; Ishida E; Konishi N
    J Pathol; 2005 Aug; 206(4):423-32. PubMed ID: 15906275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy.
    Morote J; Fernández S; Alaña L; Iglesias C; Planas J; Reventós J; Ramón Y Cajal S; Paciucci R; de Torres IM
    Clin Cancer Res; 2008 May; 14(9):2617-22. PubMed ID: 18451224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence.
    Ayala G; Thompson T; Yang G; Frolov A; Li R; Scardino P; Ohori M; Wheeler T; Harper W
    Clin Cancer Res; 2004 Oct; 10(19):6572-8. PubMed ID: 15475446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
    Das S; Roth CP; Wasson LM; Vishwanatha JK
    Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic regulators in prostatic intraepithelial neoplasia (PIN): value in prostate cancer detection and prevention.
    Zeng L; Kyprianou N
    Prostate Cancer Prostatic Dis; 2005; 8(1):7-13. PubMed ID: 15477876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical examination of the mTORC1 pathway in high grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinomas (PCa): a tissue microarray study (TMA).
    Evren S; Dermen A; Lockwood G; Fleshner N; Sweet J
    Prostate; 2010 Sep; 70(13):1429-36. PubMed ID: 20687216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/Akt2.
    Moro L; Arbini AA; Yao JL; di Sant'Agnese PA; Marra E; Greco M
    Cell Death Differ; 2009 Apr; 16(4):571-83. PubMed ID: 19079138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of prostate stem cell antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer.
    Barbisan F; Mazzucchelli R; Santinelli A; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R
    Histopathology; 2010 Oct; 57(4):572-9. PubMed ID: 20955382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
    Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
    Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOXA and PUMA expression add to clinical markers in predicting biochemical recurrence of prostate cancer patients in a survival tree model.
    Diallo JS; Aldejmah A; Mouhim AF; Péant B; Fahmy MA; Koumakpayi IH; Sircar K; Bégin LR; Mes-Masson AM; Saad F
    Clin Cancer Res; 2007 Dec; 13(23):7044-52. PubMed ID: 18056181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.